Home
>
National Drug Code (NDC)
>
LIPITOR
LIPITOR - 49299-1090-1 - (atorvastatin calcium)
Drug Information of LIPITOR
| Product NDC: | 49299-1090 |
| Proprietary Name: | LIPITOR |
| Non Proprietary Name: | atorvastatin calcium |
| Active Ingredient(s): | 10 mg/1 & nbsp; atorvastatin calcium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LIPITOR
| Product NDC: | 49299-1090 |
| Labeler Name: | PHARMAKON, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020702 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101201 |
Package Information of LIPITOR
| Package NDC: | 49299-1090-1 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (49299-1090-1) |
NDC Information of LIPITOR
| NDC Code | 49299-1090-1 |
| Proprietary Name | LIPITOR |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (49299-1090-1) |
| Product NDC | 49299-1090 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | atorvastatin calcium |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20101201 |
| Marketing Category Name | NDA |
| Labeler Name | PHARMAKON, LLC |
| Substance Name | ATORVASTATIN CALCIUM |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
